Serveur d'exploration Tocilizumab - Checkpoint (Ncbi)

Index « Auteurs » - entrée « Takeshi Suzuki »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Takeshi Shimazu < Takeshi Suzuki < Takeshi Umibe  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 6.
Ident.Authors (with country if any)Title
000044 (2007) Masashi Matsuyama ; Takeshi Suzuki ; Hiroto Tsuboi ; Satoshi Ito ; Mizuko Mamura ; Daisuke Goto ; Isao Matsumoto ; Akito Tsutsumi ; Takayuki SumidaAnti-interleukin-6 receptor antibody (tocilizumab) treatment of multicentric Castleman's disease.
000250 (2010) Masanobu Horikoshi [Japon] ; Takeshi Suzuki ; Makoto Sugihara ; Yuya Kondo ; Hiroto Tsuboi ; Takeaki Uehara ; Maasa Hama ; Kaoru Takase ; Shigeru Ohno ; Yoshiaki Ishigatsubo ; Yuri Yoshida ; Akira Sagawa ; Kei Ikeda ; Toshiyuki Ota ; Isao Matsumoto ; Satoshi Ito ; Takayuki SumidaComparison of low-field dedicated extremity magnetic resonance imaging with articular ultrasonography in patients with rheumatoid arthritis.
000654 (2013) Takeshi Suzuki [Japon] ; Masanobu Horikoshi ; Makoto Sugihara ; Tomoya Hirota ; Hiroshi Ogishima ; Naoto Umeda ; Yuya Kondo ; Hiroto Tsuboi ; Taichi Hayashi ; Yusuke Chino ; Isao Matsumoto ; Takayuki SumidaTherapeutic efficacy of tocilizumab in patients with rheumatoid arthritis refractory to anti-tumor-necrosis-factor inhibitors: 1 year follow-up with low-field extremity MRI.
000C27 (2015) Takeshi Suzuki [Japon] ; Tomoya Hirota ; Hiroshi Ogishima ; Naoto Umeda ; Yuya Kondo ; Masahiro Yokosawa ; Haruka Miki ; Hiroto Tsuboi ; Isao Matsumoto ; Takayuki SumidaSubclinical inflammation with tocilizumab treatment of rheumatoid arthritis: MRI evaluation for 2 years.
000E60 (2016) Tomoya Hirota [Japon] ; Takeshi Suzuki [Japon] ; Hiroshi Ogishima [Japon] ; Shinya Hagiwara [Japon] ; Hiroshi Ebe [Japon] ; Hiroyuki Takahashi [Japon] ; Masahiro Yokosawa [Japon] ; Naoto Umeda [Japon] ; Yuya Kondo [Japon] ; Hiroto Tsuboi [Japon] ; Isao Matsumoto [Japon] ; Takayuki Sumida [Japon]Evaluation of changes in magnetic resonance images following 24 and 52 weeks of treatment of rheumatoid arthritis with infliximab, tocilizumab, or abatacept.
002619 (2019) Wataru Fukuda ; Tadamasa Hanyu ; Masaki Katayama ; Shinichi Mizuki ; Akitomo Okada ; Masayuki Miyata ; Yuichi Handa ; Masatoshi Hayashi ; Yoshinobu Koyama ; Kaoru Arii ; Toshiyuki Kitaori ; Hiroyuki Hagiyama ; Yoshinori Urushidani ; Takahito Yamasaki ; Yoshihiko Ikeno ; Takeshi Suzuki ; Atsushi Omoto ; Toshifumi Sugitani ; Satoshi Morita ; Shigeko InokumaRisk stratification and clinical course of hepatitis B virus reactivation in rheumatoid arthritis patients with resolved infection: final report of a multicenter prospective observational study at Japanese Red Cross Hospital

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Ncbi/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Author.i -k "Takeshi Suzuki" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Author.i  \
                -Sk "Takeshi Suzuki" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Author.i
   |clé=    Takeshi Suzuki
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021